prostate cancer
Conditions
Interventions
Collect PET/CT data after intravenous administration of [18F]FSU-880 (approximately 185MBq)that is produced by automated synthetic device. PET/CT data collection is finished in 1 day.
Sponsors
Kyoto University Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1.Patients who are suspected of having recurrence due to their increased PSA or diagnostic imaging after surgery for prostate cancer 2. Patients who are determined to be appropriate for this study by participating physicians according to the results of physical examination and blood/urine/physiological function tests. 3. Patients who give us written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients having severe communication problem. 2. Patients with severe general condition. 3. Patients having severe renal dysfunction (eGFR<39mL/min/1.73m3) expected to affect the distribution of [18F]FSU-880.. 4. Patients to whom participating physicians judged to be inappropriate for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| presence or absence of abnormal uptake of FSU-880 | — |
Secondary
| Measure | Time frame |
|---|---|
| Time course of uptake and/or tumor-to-background ratio in a lesion | — |
Countries
Japan
Contacts
Public ContactYoichi Shimizu
Kyoto University Hospital Department of Radiology
Outcome results
None listed